Direkt zum Inhalt
Merck
  • The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.

The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2014-03-13)
Terence W Friedlander, Lawrence Fong
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Docetaxel, purum, ≥97.0% (HPLC)
Wasserfreies Docetaxel, European Pharmacopoeia (EP) Reference Standard